Article
Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.
Cancer biotherapy & radiopharmaceuticals - 1 Dec 2006
Ye Zhenmin, Chen Zhuang, Sami Amer, El-Gayed Ali, Xiang Jim
Abstract excerpt
Dendritic cell (DC) vaccine has been demonstrated to induce antitumor immunity in animal models. It has been shown that the efficiency of antitumor immunity by DC vaccine is closely correlated with DC maturation status. The mature human DCs generated from peripheral blood mononuclear cells (PBMCs) in the presence of granulocyte macrophage-colony-stimulating factor (GM-CSF), interleukin (IL)-4, and tumor necrosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
